August 1, 2019
Joint Commission issues new Sentinel Event Alert on managing risks of direct oral anticoagulants
Editor's Note
In response to an increase in adverse events related to direct oral anticoagulants (DOACs), the Joint Commission, on July 31, issued a new Sentinel Event Alert on managing DOAC risks.
The alert:
- provides guidance for safe use and management of DOACs
- stresses understanding the risks, benefits, side effects, and reversal agents for all anticoagulants.
The alert has an accompanying infographic on “10 ways to be prepared to treat patients on direct oral anticoagulants (DOACs).”
Free Daily News
- Neurosurgery trial: Early evacuation improves long-term hemorrhage outcomes
- Drug shortages higher than ever
- FDA announces class 1 recalls for premixed embolic, infusion pump software
- Academic medical centers identify performance-improvement priorities
- Propofol anesthesia for colonoscopy could help find polyps, prevent cancer
- FDA Class 1 recall renews concern about historically problematic heart pumps
- New physician compensation report reveals modest pay gains but growing discontent with the profession
- Surge in corporate ownership of medical practices raises concerns over physician autonomy, care quality
- How Minneapolis healthcare real estate remained strong amid challenges, shifts in patient care preferences: Lessons for other states
- Artificial intelligence (AI) captures uncertainty in medical scans
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging